Sociedad Americana de Hirudoterapia

Preventing infective complications following leech therapy: elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana using antibiotic feeding

Research article published in Surgical Infections (2014)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportSeguridad y control de infeccionesLitwinowicz A, Blaszkowska J · Surgical infections, 2014

Abstract

BACKGROUND: Hirudotherapy is often used successfully in modern medicine, especially in plastic and reconstructive surgery. However, Aeromonas infections are the most common complications of post-operative leech application. Hence, prophylactic antibiotic administration is recommended before and during leech therapy. It has been confirmed that patient safety and achieving the desired therapeutic effect depend mainly on the microbiologic purity of the animals used. The aims of this study were to find a safe and practical way to eradicate symbiotic Aeromonas spp. occuring in the intestine of Hirudo verbana. METHODS: Leeches were fed artificially with 1.5 mL of sterile defibrinated sheep blood supplemented with ciprofloxacin (CIP) or cefotaxime (CTX), at bacteriostatic concentrations of 0.2 mcg/mL or 1.5 mcg/mL, and bactericidal concentrations of 20 mcg/mL or 50 mcg/mL, respectively. Bacteria were isolated from the leech intestines before and after feeding at different time intervals: 1, 7, 14, 21, and 28 d. RESULTS: Biochemical identification of bacterial isolates from water samples and intestines of H. verbana using the API-NE20 test showed that A. veronii biovar sobria was predominant. Bacteria belonging to the genus Aeromonas were detected in all control leeches. The results showed that optimum eradication of bacteria from leech intestines was obtained using 20 mcg/mL of CIP and 50 mcg/mL of CTX, which decreased the number of Aeromonas spp. to undetectable levels for two weeks after feeding in all treated leeches. A statistically significant reduction in the number of bacterial colonies (p<0.0001) was observed in leeches treated with bacteriostatic concentrations of CIP or CTX; no bacterial growth was found on the plates after only seven days of feeding with antibiotics. All water samples in which the leeches were kept before treatment were contaminated with Aeromonas spp., whereas these samples were negative after antibiotic feeding of animals. CONCLUSIONS: All leeches were ready to take a blood meal after treatment, suggesting the possibility of using ciprofloxacin-treated or cefotaxime-treated leeches instead of chemoprophylaxis in patients undergoing hirudotherapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAeromonasAnimal FeedAnimalsAnti-Bacterial AgentsDietGram-Negative Bacterial InfectionsHumansIntestinesLeechesLeeching

Resumen

Feeding Hirudo verbana with sterile sheep blood supplemented with ciprofloxacin (20 µg/mL) or cefotaxime (50 µg/mL) eradicated symbiotic Aeromonas spp. from leech intestines for two weeks, supporting decontamination as an alternative to patient chemoprophylaxis.

Por qué esto importa para la hirudoterapia

Este estudio investigó un método para erradicar Aeromonas spp. simbióticas del intestino de sanguijuelas Hirudo verbana alimentándolas con sangre estéril de oveja suplementada con antibióticos. Se encontró que concentraciones bactericidas de ciprofloxacino o cefotaxima lograron reducir Aeromonas a niveles indetectables durante dos semanas, lo que sugiere que estas sanguijuelas tratadas podrían usarse en hirudoterapia en lugar de la quimioprofilaxis estándar del paciente. Esto es altamente relevante para el dominio de la ASH, ya que propone una solución proactiva y preventiva para la complicación infecciosa más común de la terapia con sanguijuelas, al garantizar la pureza microbiológica de los animales. Sin embargo, los hallazgos se limitan actualmente a un estudio experimental que involucra la alimentación de las sanguijuelas, sin datos clínicos en humanos que confirmen si esto previene eficazmente las infecciones en pacientes quirúrgicos reales.

Citación

Preventing infective complications following leech therapy: elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana using antibiotic feeding.

Litwinowicz A, Blaszkowska J · Surgical infections, 2014

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.